Brand Name
Reclast
Generic Name
Zoledronic
View Brand Information FDA approval date: April 01, 2007
Classification: Bisphosphonate
Form: Injection
What is Reclast (Zoledronic)?
Zoledronic Acid Injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment